🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
GE Healthcare has recently submitted a New Drug Application (NDA) for Ioben...
Status
Approved For Marketing
Location
GE Healthcare
Start Date
TBD
Trial ID
NCT00730444
Treatments Being Tested
The purpose of this study is to demonstrate correlation of the H/M ratio of...
Status
Completed
Location
Cardiovascular Imaging Technologies
Start Date
2013-12
Trial ID
NCT01868841
Treatments Being Tested
The aim of the study was to assess the reproducibility of quantitative meas...
Status
Completed
Location
GE Healthcare
Start Date
2013-08
Trial ID
NCT01936649
Treatments Being Tested
This study is being done with a radioisotope, 123I-mIBG (Adreview), to deve...
Status
Completed
Location
University of Ottawa Heart Institute
Start Date
2013-12
Trial ID
NCT02043522
Treatments Being Tested
Subjects were recruited if their healthcare provider decided that they need...
Status
Terminated
Location
Mayo Clinic in Rochester
Start Date
2012-02
Trial ID
NCT01522378
Treatments Being Tested
This phase III trial studies iobenguane I-131 or lorlatinib and standard th...
Status
Recruiting
Location
Children's Hospital of Alabama
Start Date
2018-05-14
Trial ID
NCT03126916
Treatments Being Tested
This phase II trial studies if dinutuximab, GM-CSF, isotretinoin in combina...
Status
Active Not Recruiting
Location
Banner Children's at Desert
Start Date
2020-12-31
Trial ID
NCT04385277
The goal of this exploratory study is to test whether \[18F\]3F-PHPG can be...
Status
Completed
Location
University of Michigan Rogel Cancer Center
Start Date
2020-10-19
Trial ID
NCT04510311
This aim of the study is to investigate the prognostic usefulness of AdreVi...
Status
Completed
Location
GE Healthcare
Start Date
2014-02
Trial ID
NCT02127307
This is an event-driven Phase IIIb, multicentre, randomised, clinical study...
Status
Terminated
Location
Vascular Biology and Hypertension Program, University of Alabama at Birmingham
Start Date
2015-12-30
Trial ID
NCT02656329